Diroximel fumarate pregnancy outcomes in EVOLVE-MS-1 and prospective MS pregnancy exposure registry...
Diroximel fumarate pregnancy outcomes in EVOLVE-MS-1 and prospective MS pregnancy exposure registry study design
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
ObjectiveReport pregnancy outcomes from diroximel fumarate (DRF)-exposed women with multiple sclerosis (MS) in EVOLVE-MS-1, and describe a prospective, international pregnancy registry of women with MS (BlossoMS).BackgroundDRF is a next-generation oral fumarate approved for relapsing forms of MS. There are limited data on developmental risks associ...
Alternative Titles
Full title
Diroximel fumarate pregnancy outcomes in EVOLVE-MS-1 and prospective MS pregnancy exposure registry study design
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2894670552
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2894670552
Other Identifiers
ISSN
0022-3050
E-ISSN
1468-330X
DOI
10.1136/JNNP-2023-ABN.206
